Integra LifeSciences Holdings Corp Stock
Currently there is a rather negative sentiment for Integra LifeSciences Holdings Corp with 3 Buy predictions and 5 Sell predictions..
On the other hand, the target price of 34 € is above the current price of 25.2 € for Integra LifeSciences Holdings Corp, so the potential is actually 34.92%.
Pros and Cons of Integra LifeSciences Holdings Corp in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Integra LifeSciences Holdings Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corp | - | 4.132% | -14.286% | -45.217% | -36.041% | -56.174% | -42.544% |
| Neogen Corp. | 2.480% | 9.735% | 12.727% | -18.954% | -32.240% | -66.933% | -52.932% |
| Bio-Rad Labs Inc. A | -1.000% | 2.673% | 1.779% | -23.997% | -8.413% | -44.442% | - |
| Merit Medical Systems | -0.670% | 0.000% | 9.630% | -5.128% | 8.824% | 48.594% | 54.877% |
Comments
Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target lowered by analysts at Morgan Stanley from $37.00 to $24.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target lowered by analysts at Bank of America Co. from $42.00 to $26.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for IART provided by MarketBeat